Press / media

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

12.11.2026

Fraunhofer IZI is supporting DAiNA in the development of an AI-based platform for personalized tumor therapy

DAiNA combines artificial intelligence (AI) with high-resolution molecular analysis to gain a more precise understanding of individual tumors and develop tailored treatment strategies.
more info

10.11.2026

New Approach to Type 2 Diabetes

The Fraunhofer Institute for Cell Therapy and Immunology IZI is supporting Viacure Therapeutics on its path to clinical testing of a new antibody therapy for type 2 diabetes.
more info

6.10.2026

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Fraunhofer Institute for Cell Therapy and Immunology IZI and the Max Planck Institute for Medical Research (MPIMR) are collaborating on new research approaches to advance the development of cell-based immunotherapies. The three-year project is funded through the Fraunhofer–Max Planck Cooperation Program.
more info

18.9.2026

Focus on Translation and Transfer: Fraunhofer IZI at the “Würzburg Day of Future Medicine” aboard the MS Wissenschaft

From September 8 to 11, the floating science center MS Wissenschaft was moored in Würzburg. Its exhibits included a presentation on CAR T-cell therapy developed by the University of Würzburg, Würzburg University Hospital, and Fraunhofer IZI.
more info

Archive news and press releases

RSS Newsfeed

Get the latest news about the Fraunhofer IZI. Through our RSS-feed you have the opportunity to follow all our press releases and receive them right when they are published.

Social media

 

Media library

 

Publications

 

Events